What's new

Human medicines European public assessment report (EPAR): Nimenrix, meningococcal groups A, C, W-135 and Y conjugate vaccine, Date of authorisation: 20/04/2012, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Nimenrix, meningococcal groups A, C, W-135 and Y conjugate vaccine, Date of authorisation: 20/04/2012, Revision: 41, Status: Authorised

Feb 13, 2025 - 16:45
 0
Human medicines European public assessment report (EPAR): Nimenrix, meningococcal groups A, C, W-135 and Y conjugate vaccine, Date of authorisation: 20/04/2012, Revision: 41, Status: Authorised
Human medicines European public assessment report (EPAR): Nimenrix, meningococcal groups A, C, W-135 and Y conjugate vaccine, Date of authorisation: 20/04/2012, Revision: 41, Status: Authorised
Read More

Tags:

Previous Article

Radisson Hotel Group marks the debut of Park Inn & Suites brand in Bengaluru, wi...

Next Article

Human medicines European public assessment report (EPAR): Ruxience, rituximab, D...

Related Posts

Human medicines European public assessment report (EPAR): Cinqaero, reslizumab, Date of authorisation: 15/08/2016, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 11, 2025  0

Human medicines European public assessment report (EPAR): Lysodren, mitotane, Date of authorisation: 28/04/2004, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 8, 2025  0

Human medicines European public assessment report (EPAR): Inovelon, rufinamide, Date of authorisation: 16/01/2007, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 15, 2025  0